Megan Cole

Nov 1, 2024 | science.org | Spencer Shelton |Megan Cole |Mengjie Zhang |Sara House

AbstractMitochondrial DNA (mtDNA) mutations are frequent in cancer, yet their precise role in cancer progression remains debated. To functionally evaluate the impact of mtDNA variants on tumor growth and metastasis, we developed an enhanced cytoplasmic hybrid (cybrid) generation protocol and established isogenic human melanoma cybrid lines with wild-type mtDNA or pathogenic mtDNA mutations with partial or complete loss of mitochondrial oxidative function.

Aug 7, 2024 | houstonpublicmedia.org | Megan Cole

Episode: 2751 Mrs. Maud Mellish Wilson, architect of the Mayo Clinic’s style of medical writing. Today, we look at a woman who made medical history.

Aug 5, 2024 | jamanetwork.com | Mathias Lalika |Kevin Nguyen |Nicole Giron |Megan Cole

Harnessing Social Needs Data to Advance Health Equity in Federally Qualified Health Centers As of 2023, more than 25 million people in the US lack health insurance.1 Unfortunately, even insured patients, particularly Medicaid beneficiaries and older Medicare recipients, still face restricted health care access due to excessive costs or reimbursement-related barriers.2 To tackle these challenges, the US government supports federally qualified health centers (FQHCs), nonprofit clinics...

Jun 11, 2024 | lexology.com | Amanda Stark |Megan Cole

Reducing examination wait times in New ZealandIn our second article of this four part series, Practice Group Leader – ChemLife, Amanda Stark and Patent Attorney, Dr Megan Cole, provide tips and tricks for bypassing examination wait times in New Zealand so the end goal – a granted patent – is reached expediently.

Mar 26, 2024 | lexology.com | Amanda Stark |Megan Cole

Part 1- Reducing examination wait times in AustraliaIn our first article of a four part series, Practice Group Leader – ChemLife, Amanda Stark and Patent Attorney, Dr Megan Cole, provide some tips and tricks for bypassing examination wait times in Australia so the end goal – a granted patent – is reached expediently.